Actively Recruiting
Pharmacokinetic Study of Phytochemicals in Whole-Grain and Refined Corn Using a Randomized Crossover Design
Led by North Carolina Agriculture & Technical State University · Updated on 2026-08-24
16
Participants Needed
1
Research Sites
5 weeks
Total Duration
AI-Summary
What This Trial Is About
Researchers are conducting a randomized crossover pharmacokinetic study to identify biomarkers of whole-grain corn intake in healthy adults aged 25 to 70 years. The study aims to understand how the body absorbs, processes, and eliminates whole-grain corn phytochemicals and to develop analytical methods for measuring these biomarkers. This research may help build a database of whole-grain metabolites commonly consumed by Americans. Participants will avoid whole-grain products for 7 days before the intervention. On Day 8, they will consume two servings of either whole-grain or refined corn, with blood and urine samples collected over 48 hours. After a 6-day washout, participants will cross over to the alternate corn type on Day 15, with repeated sample collection. This allows comparison of metabolite profiles between whole-grain and refined corn intake. During the study, baseline fecal samples are collected before the first intervention. Participants provide blood and urine samples at multiple time points following each corn consumption visit to measure metabolite concentrations. Researchers will analyze changes from baseline in plasma and urine metabolites over 48 hours after intake. The total participation spans about three weeks, including dietary restrictions, interventions, and sample collections.
CONDITIONS
Brief Title
Pharmacokinetic (PK) Study of Phytochemicals in Whole Grains (WGs)- Corn
Research Team
S
Shengmin Sang
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here